Wherry EJ Blattman JN Murali-Krishna K van der Most R Ahmed R. Viral persistence alters CD8 T-cell immunodominance and tissue distribution and results in distinct stages of functional impairment. J Virol. (2003) 77:4911–27. doi: 10.1128/JVI.77.8.4911-4927.2003, PMID: 12663797
Barber DL Wherry EJ Masopust D Zhu B Allison JP Sharpe AH et al. Restoring function in exhausted CD8 T cells during chronic viral infection. Nature. (2006) 439:682–7. doi: 10.1038/nature04444, PMID: 16382236
Frebel H Nindl V Schuepbach RA Braunschweiler T Richter K Vogel J et al. Programmed death 1 protects from fatal circulatory failure during systemic virus infection of mice. J Exp Med. (2012) 209:2485–99. doi: 10.1084/jem.20121015, PMID: 23230000
Ahn E Araki K Hashimoto M Li W Riley JL Cheung J et al. Role of PD-1 during effector CD8 T cell differentiation. Proc Natl Acad Sci U.S.A. (2018) 115:4749–54. doi: 10.1073/pnas.1718217115, PMID: 29654146
Utzschneider DT Legat A Fuertes Marraco SA Carrie L Luescher I Speiser DE et al. T cells maintain an exhausted phenotype after antigen withdrawal and population reexpansion. Nat Immunol. (2013) 14:603–10. doi: 10.1038/ni.2606, PMID: 23644506
Sheppard KA Fitz LJ Lee JM Benander C George JA Wooters J et al. PD-1 inhibits T-cell receptor induced phosphorylation of the ZAP70/CD3zeta signalosome and downstream signaling to PKCtheta. FEBS Lett. (2004) 574:37–41. doi: 10.1016/j.febslet.2004.07.083, PMID: 15358536
Patsoukis N Brown J Petkova V Liu F Li L Boussiotis VA. Selective effects of PD-1 on Akt and Ras pathways regulate molecular components of the cell cycle and inhibit T cell proliferation. Sci Signal. (2012) 5:ra46. doi: 10.1126/scisignal.2002796, PMID: 22740686
Hui E Cheung J Zhu J Su X Taylor MJ Wallweber HA et al. T cell costimulatory receptor CD28 is a primary target for PD-1-mediated inhibition. Science. (2017) 355:1428–33. doi: 10.1126/science.aaf1292, PMID: 28280247
Sandu I Cerletti D Claassen M Oxenius A. Exhausted CD8(+) T cells exhibit low and strongly inhibited TCR signaling during chronic LCMV infection. Nat Commun. (2020) 11:4454. doi: 10.1038/s41467-020-18256-4, PMID: 32901001
Wherry EJ Ha SJ Kaech SM Haining WN Sarkar S Kalia V et al. Molecular signature of CD8+ T cell exhaustion during chronic viral infection. Immunity. (2007) 27:670–84. doi: 10.1016/j.immuni.2007.09.006, PMID: 17950003
Martinez GJ Pereira RM Aijo T Kim EY Marangoni F Pipkin ME et al. The transcription factor NFAT promotes exhaustion of activated CD8+ T cells. Immunity. (2015) 42:265–78. doi: 10.1016/j.immuni.2015.01.006, PMID: 25680272
Khan O Giles JR McDonald S Manne S Ngiow SF Patel KP et al. TOX transcriptionally and epigenetically programs CD8(+) T cell exhaustion. Nature. (2019) 571:211–8. doi: 10.1038/s41586-019-1325-x, PMID: 31207603
Alfei F Kanev K Hofmann M Wu M Ghoneim HE Roelli P et al. TOX reinforces the phenotype and longevity of exhausted T cells in chronic viral infection. Nature. (2019) 571:265–9. doi: 10.1038/s41586-019-1326-9, PMID: 31207605
Scott AC Dundar F Zumbo P Chandran SS Klebanoff CA Shakiba M et al. TOX is a critical regulator of tumour-specific T cell differentiation. Nature. (2019) 571:270–4. doi: 10.1038/s41586-019-1324-y, PMID: 31207604
Odorizzi PM Pauken KE Paley MA Sharpe A Wherry EJ. Genetic absence of PD-1 promotes accumulation of terminally differentiated exhausted CD8+ T cells. J Exp Med. (2015) 212:1125–37. doi: 10.1084/jem.20142237, PMID: 26034050
Utzschneider DT Charmoy M Chennupati V Pousse L Ferreira DP Calderon-Copete S et al. T cell factor 1-expressing memory-like CD8(+) T cells sustain the immune response to chronic viral infections. Immunity. (2016) 45:415–27. doi: 10.1016/j.immuni.2016.07.021, PMID: 27533016
Im SJ Hashimoto M Gerner MY Lee J Kissick HT Burger MC et al. Defining CD8+ T cells that provide the proliferative burst after PD-1 therapy. Nature. (2016) 537:417–21. doi: 10.1038/nature19330, PMID: 27501248
Hudson WH Gensheimer J Hashimoto M Wieland A Valanparambil RM Li P et al. Proliferating transitory T cells with an effector-like transcriptional signature emerge from PD-1(+) stem-like CD8(+) T cells during chronic infection. Immunity. (2019) 51:1043–1058 e4. doi: 10.1016/j.immuni.2019.11.002, PMID: 31810882
Hashimoto M Araki K Cardenas MA Li P Jadhav RR Kissick HT et al. PD-1 combination therapy with IL-2 modifies CD8 T cell exhaustion program. Nat. (2022), 610173–+. doi: 10.1038/s41586-022-05257-0, PMID: 36171288
Moran AE Holzapfel KL Xing Y Cunningham NR Maltzman JS Punt J et al. T cell receptor signal strength in T and iNKT cell development demonstrated by a novel fluorescent reporter mouse. J Exp Med. (2011) 208:1279–89. doi: 10.1084/jem.20110308, PMID: 21606508
Elliot TAE Jennings EK Lecky DAJ Thawait N Flores-Langarica A Copland A et al. Antigen and checkpoint receptor engagement recalibrates T cell receptor signal strength. Immunity. (2021) 54:2481–2496 e6. doi: 10.1016/j.immuni.2021.08.020, PMID: 34534438
Liu X Berry CT Ruthel G Madara JJ MacGillivray K Gray CM et al. T cell receptor-induced nuclear factor kappaB (NF-kappaB) signaling and transcriptional activation are regulated by STIM1- and orai1-mediated calcium entry. J Biol Chem. (2016) 291:8440–52. doi: 10.1074/jbc.M115.713008, PMID: 26826124
Gautam S Fioravanti J Zhu W Le Gall JB Brohawn P Lacey NE et al. The transcription factor c-Myb regulates CD8(+) T cell stemness and antitumor immunity. Nat Immunol. (2019) 20:337–49. doi: 10.1038/s41590-018-0311-z, PMID: 30778251
Tsui C Kretschmer L Rapelius S Gabriel SS Chisanga D Knopper K et al. MYB orchestrates T cell exhaustion and response to checkpoint inhibition. Nature. (2022). 609:354–60. doi: 10.1038/s41586-022-05105-1, PMID: 35978192
Pais Ferreira D Silva JG Wyss T Fuertes Marraco SA Scarpellino L Charmoy M et al. Central memory CD8(+) T cells derive from stem-like Tcf7(hi) effector cells in the absence of cytotoxic differentiation. Immunity. (2020) 53:985–1000 e11. doi: 10.1016/j.immuni.2020.09.005, PMID: 33128876
Yamada T Park CS Mamonkin M Lacorazza HD. Transcription factor ELF4 controls the proliferation and homing of CD8+ T cells via the Kruppel-like factors KLF4 and KLF2. Nat Immunol. (2009) 10:618–26. doi: 10.1038/ni.1730, PMID: 19412182
Gill AL Wang PH Lee J Hudson WH Ando S Araki K et al. PD-1 blockade increases the self-renewal of stem-like CD8 T cells to compensate for their accelerated differentiation into effectors. Sci Immunol. (2023) 8:eadg0539. doi: 10.1126/sciimmunol.adg0539, PMID: 37624909
Ngiow SF Manne S Huang YJ Azar T Chen Z Mathew D et al. LAG-3 sustains TOX expression and regulates the CD94/NKG2-Qa-1b axis to govern exhausted CD8 T cell NK receptor expression and cytotoxicity. Cell. (2024) 187:4336–4354 e19. doi: 10.1016/j.cell.2024.07.018, PMID: 39121847
Park SM Cho H Thornton AM Barlowe TS Chou T Chhangawala S et al. IKZF2 drives leukemia stem cell self-renewal and inhibits myeloid differentiation. Cell Stem Cell. (2019) 24:153–165 e7. doi: 10.1016/j.stem.2018.10.016, PMID: 30472158
Joncker NT Shifrin N Delebecque F Raulet DH. Mature natural killer cells reset their responsiveness when exposed to an altered MHC environment. J Exp Med. (2010) 207:2065–82. doi: 10.1084/jem.20100570, PMID: 20819928
Kim S Poursine-Laurent J Truscott SM Lybarger L Song YJ Yang L et al. Licensing of natural killer cells by host major histocompatibility complex class I molecules. Nature. (2005) 436:709–13. doi: 10.1038/nature03847, PMID: 16079848
Guia S Jaeger BN Piatek S Mailfert S Trombik T Fenis A et al. Confinement of activating receptors at the plasma membrane controls natural killer cell tolerance. Sci Signal. (2011) 4:ra21. doi: 10.1126/scisignal.2001608, PMID: 21467299
Salerno F Guislain A Freen-Van Heeren JJ Nicolet BP Young HA Wolkers MC. Critical role of post-transcriptional regulation for IFN-gamma in tumor-infiltrating T cells. Oncoimmunology. (2019) 8:e1532762. doi: 10.1080/2162402X.2018.1532762, PMID: 30713785
Salerno F Engels S van den Biggelaar M Alphen FPJv Guislain A Zhao W et al. Translational repression of pre-formed cytokine-encoding mRNA prevents chronic activation of memory T cells. Nat Immunol. (2018) 19:828–37. doi: 10.1038/s41590-018-0155-6, PMID: 29988089
Nicolaides NC Correa I Casadevall C Travali S Soprano KJ Calabretta B. The Jun family members, c-Jun and JunD, transactivate the human c-myb promoter via an Ap1-like element. J Biol Chem. (1992) 267:19665–72. doi: 10.1016/S0021-9258(18)41826-1, PMID: 1527086
Nah J Seong RH. Kruppel-like factor 4 regulates the cytolytic effector function of exhausted CD8 T cells. Sci Adv. (2022) 8:eadc9346. doi: 10.1126/sciadv.adc9346, PMID: 36427304
Takahashi K Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell. (2006) 126:663–76. doi: 10.1016/j.cell.2006.07.024, PMID: 16904174
Siddiqui I Schaeuble K Chennupati V Fuertes Marraco SA Calderon-Copete S Pais Ferreira D et al. Intratumoral tcf1(+)PD-1(+)CD8(+) T cells with stem-like properties promote tumor control in response to vaccination and checkpoint blockade immunotherapy. Immunity. (2019) 50:195–211 e10. doi: 10.1016/j.immuni.2018.12.021, PMID: 30635237
Miller BC Sen DR Al Abosy R Bi K Virkud YV LaFleur MW et al. Subsets of exhausted CD8(+) T cells differentially mediate tumor control and respond to checkpoint blockade. Nat Immunol. (2019) 20:326–36. doi: 10.1038/s41590-019-0312-6, PMID: 30778252
Pauken KE Sammons MA Odorizzi PM Manne S Godec J Khan O et al. Epigenetic stability of exhausted T cells limits durability of reinvigoration by PD-1 blockade. Sci (New York N Y). (2016) 354:1160–5. doi: 10.1126/science.aaf2807, PMID: 27789795
Nishimura H Minato N Nakano T Honjo T. Immunological studies on PD-1 deficient mice: implication of PD-1 as a negative regulator for B cell responses. Int Immunol. (1998) 10:1563–72. doi: 10.1093/intimm/10.10.1563, PMID: 9796923
Pircher H Mak TM Lang R Ballhausen W Ruedi E Hengartner H et al. T cell tolerance to Mlsa encoded antigens in T cell receptor Vb8. 1 Transgenic mice. EMBO J. (1989) 8:719–27. doi: 10.1002/j.1460-2075.1989.tb03431.x, PMID: 2524380
Dillon SR Jameson SC Fink PJ. V beta 5+ T cell receptors skew toward OVA+H-2Kb recognition. J Immunol. (1994) 152:1790–801. doi: 10.4049/jimmunol.152.4.1790, PMID: 8120388
Battegay M Cooper S Althage A Banziger J Hengartner H Zinkernagel RM. Quantification of lymphocytic choriomeningitis virus with an immunological focus assay in 24- or 96-well plates. J Virol Methods. (1991) 33:191–8. doi: 10.1016/0166-0934(91)90018-U, PMID: 1939506
Martin M. Cutadapt removes adapter sequences from high-throughput sequencing reads. EMBnet J. (2011) 17:10–2. doi: 10.14806/ej.17.1.200
Davis MP van Dongen S Abreu-Goodger C Bartonicek N Enright AJ. Kraken: a set of tools for quality control and analysis of high-throughput sequence data. Methods. (2013) 63:41–9. doi: 10.1016/j.ymeth.2013.06.027, PMID: 23816787
Dobin A Davis CA Schlesinger F Drenkow J Zaleski C Jha S et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics. (2013) 29:15–21. doi: 10.1093/bioinformatics/bts635, PMID: 23104886
Anders S Pyl PT Huber W. HTSeq--a Python framework to work with high-throughput sequencing data. Bioinformatics. (2015) 31:166–9. doi: 10.1093/bioinformatics/btu638, PMID: 25260700
Wang L Wang S Li W. RSeQC: quality control of RNA-seq experiments. Bioinformatics. (2012) 28:2184–5. doi: 10.1093/bioinformatics/bts356, PMID: 22743226
Team RC. R: A language and environmenet for statistical computing. Vienna, Austria: R Foundation for Statistical Computing (2017).
Robinson MD Oshlack A. A scaling normalization method for differential expression analysis of RNA-seq data. Genome Biol. (2010) 11:R25. doi: 10.1186/gb-2010-11-3-r25, PMID: 20196867
Ritchie ME Phipson B Wu D Hu Y Law CW Shi W et al. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. (2015) 43:e47. doi: 10.1093/nar/gkv007, PMID: 25605792
Law CW Chen Y Shi W Smyth GK. voom: Precision weights unlock linear model analysis tools for RNA-seq read counts. Genome Biol. (2014) 15:R29. doi: 10.1186/gb-2014-15-2-r29, PMID: 24485249
Phipson B Lee S Majewski IJ Alexander WS Smyth GK. Robust hyperparameter estimation protects against hypervariable genes and improves power to detect differential expression. Ann Appl Stat. (2016) 10:946–63. doi: 10.1214/16-AOAS920, PMID: 28367255
Hochberg Y Benjamini Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc Ser B. (1995) 57:289–300. doi: 10.1111/j.2517-6161.1995.tb02031.x
Wu T Hu E Xu S Chen M Guo P Dai Z et al. clusterProfiler 4.0: A universal enrichment tool for interpreting omics data. Innovation. (2021) 2:100141. doi: 10.1016/j.xinn.2021.100141, PMID: 34557778
Schaefer CF Anthony K Krupa S Buchoff J Day M Hannay T et al. PID: the pathway interaction database. Nucleic Acids Res. (2009) 37:D674–9. doi: 10.1093/nar/gkn653, PMID: 18832364
Subramanian A Tamayo P Mootha VK Mukherjee S Ebert BL Gillette MA et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U.S.A. (2005) 102:15545–50. doi: 10.1073/pnas.0506580102, PMID: 16199517
Stuart T Butler A Hoffman P Hafemeister C Papalexi E Mauck WM et al. Comprehensive integration of single-cell data. Cell. (2019) 177:1888–1902 e21. doi: 10.1016/j.cell.2019.05.031, PMID: 31178118
Liberzon A Birger C Thorvaldsdottir H Ghandi M Mesirov JP Tamayo P. The Molecular Signatures Database (MSigDB) hallmark gene set collection. Cell Syst. (2015) 1:417–25. doi: 10.1016/j.cels.2015.12.004, PMID: 26771021
Blattman JN Antia R Sourdive DJ Wang X Kaech SM Murali-Krishna K et al. Estimating the precursor frequency of naive antigen-specific CD8 T cells. J Exp Med. (2002) 195:657–64. doi: 10.1084/jem.20001021, PMID: 11877489
